Suitability depends on the condition, cell type, plans permitted under Korean law, and an individual assessment. The EHL team reviews your health information and explains the available options before confirming a care plan.
When reading stem cell news, first check whether the study was in animals, in cultured cells, or in humans — a result in mice does not transfer to people. Second, check the phase: a phase 1 study targets safety only, not proof of treatment. Third, check participant numbers; ten participants cannot support the same conclusions as several hundred. Fourth, check follow-up duration, because chronic disease requires years of follow-up to show real effect. Fifth, check who funded the work and who reported it — news based on a press release should always be checked against a trial registry or the original journal article. Any claim of a cure, guaranteed results, or use in every disease should be treated as a warning sign.
Source: ClinicalTrials.gov and PubMed
Experts behind this content
EHL Thailand Research Desk — Careful reading of study results, including sample size, trial phase and limitations
EHL BIO scientific information is compiled alongside public information from its research team and GMP centre. See the full expert panel